Sofinnova Partners

Venture Capital Active London, United Kingdom Est. 1972
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
2
Rounds' value
$42.0M
total disclosed, rounds participated
Stages
A Round, Seed

About

Sofinnova Partners is a European venture capital firm focused on life sciences, with core specializations in healthcare and sustainability. Headquartered in Paris, with additional offices in London and Milan, the firm combines scientific, medical, and business expertise to support companies across the full lifecycle of venture investment. Its approach includes hands-on company building, from seed-stage formation to later-stage growth, working closely with entrepreneurs as a lead or cornerstone investor to advance technologies with broad societal impact.

Established in 1972, Sofinnova Partners is one of Europe’s longest-standing life sciences investors. Over five decades, it has backed more than 500 companies and contributed to the development of multiple global market leaders. The firm currently manages over €4 billion across its investment strategies.

Portfolio · 2

Endoron Medical
Catheter-based Endovascular Suturing Device for Abdominal Aortic Aneurysms
Led ★ 2 rounds $15.0M committed Latest: 2024-07
Pi-Cardia
Non-implant-based Valve Treatment
Led ★ 1 round $27.0M committed Latest: 2020-04

Investment activity

Portfolio by sector

Health Tech & Life Sciences2

Funds · 1

  • 11 — $750M Nov 2025

Q&A

What is Sofinnova Partners' primary investment focus?
Sofinnova Partners is a European venture capital firm focused on life sciences, with core specializations in healthcare and sustainability.
When was Sofinnova Partners established?
Sofinnova Partners was established in 1972, making it one of Europe’s longest-standing life sciences investors.
What is the total AUM managed by Sofinnova Partners?
Sofinnova Partners currently manages over €4 billion across its investment strategies.
What are some notable portfolio companies of Sofinnova Partners?
Sofinnova Partners' portfolio includes Endoron Medical, which is developing a catheter-based endovascular suturing device, and Pi-Cardia, focused on non-implant-based valve treatment.
What was a recent fund closed by Sofinnova Partners?
In November 2025, Sofinnova Partners closed Fund 11, raising $750M.
What investment stages does Sofinnova Partners typically engage in?
Sofinnova Partners typically invests in Seed and A Round stages, and has also participated in C Round investments.
Where is Sofinnova Partners headquartered?
Sofinnova Partners is headquartered in Paris, with additional offices in London and Milan.
What is the investment range for Sofinnova Partners?
Sofinnova Partners' investment range is typically between $5M and $27M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)